Skip to main content
logo
Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.600
-0.030 (-1.14%)
Jun 1, 2026, 4:08 PM HKT

Hua Medicine (Shanghai) Revenue

In the year 2025, Hua Medicine (Shanghai) had annual revenue of 492.93M CNY with 92.63% growth. Hua Medicine (Shanghai) had revenue of 275.50M in the half year ending December 31, 2025, with 4,287.67% growth.

Revenue
492.93M CNY
Revenue Growth
+92.63%
P/S Ratio
4.78
Revenue / Employee
1.50M CNY
Employees
328
Market Cap
2.62B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025492.93M237.04M92.63%
Dec 31, 2024255.89M179.28M234.02%
Dec 31, 202376.61M59.01M335.31%
Dec 31, 202217.60M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chia Tai Enterprises International3.68B
China Shineway Pharmaceutical Group3.49B
Edding Genor Group Holdings2.77B
Essex Bio-Technology1.81B
Jacobson Pharma Corporation1.53B
Beijing Tong Ren Tang Chinese Medicine Company1.51B
Dawnrays Pharmaceutical (Holdings)1.37B
Golden Throat Holdings Group Company1.05B
Revenue Rankings

Hua Medicine (Shanghai) News

More News